Pulnovo Medical
↗Nanjing, China
Pulnovo Medical is a clinical-stage medical device company specializing in the development of innovative interventional therapies for pulmonary hypertension (PH) and heart failure (HF). Founded in 2013, the company is a pioneer in the field of Pulmonary Artery Denervation (PADN), a minimally invasive procedure that uses radiofrequency ablation to target the pulmonary vascular sympathetic nerves, thereby reducing pulmonary artery pressure and slowing disease progression.
The company has established a global presence with offices in Nanjing, Wuxi, Beijing, Shanghai, Seattle (USA), and Singapore. Its flagship PADN technology has received the FDA's Breakthrough Device Designation and is currently undergoing pivotal global multicenter trials. Pulnovo Medical is recognized for bridging the gap between laboratory innovation and commercial application in the cardiovascular and pulmonary intervention space.
CLASSIFICATION
Company Type:MedTech
Therapeutic Areas:-
Industry:Medical Devices
Sub-Industry:Interventional Cardiology
SIZE & FINANCIALS
Employees:51-200
Revenue:$10M-$50M
Founded:2013
Ownership:private
Status:operating
FUNDING
Stage:Series C
Total Raised:$115M
Investors:Qiming Venture Partners, Lilly Asia Ventures, OrbiMed, Gaorong Capital, JI Capital Partners
PIPELINE
Stage:Commercial
Lead Drug Stage:Pivotal/Phase 3 (Global)
Modalities:Radiofrequency Ablation, Interventional Catheters
Active Trials:5
Trial Phases:Phase 1: 1 | Phase 2: 2 | Phase 3: 2
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Subsidiaries:Pulnovo Medical (Wuxi) Co., Ltd., Pulnovo Medical US
Key Partnerships:Al Qassimi Hospital (Sharjah), Nanjing Medical University, Various global clinical trial sites in Portugal, Serbia, and Georgia
COMPETITION
Position:Leader
Competitors:SoniVie, Aria CV, ReCor Medical, Medtronic (Renal Denervation division)
LEADERSHIP
Key Executives:
Cynthia Chen - Executive Chairwoman & President
Jessie Lian - CEO
Dr. Shao-Liang Chen - Clinical Founder
Scientific Founders:Dr. Shao-Liang Chen
Board Members:Cynthia Chen, William Hu (Qiming Venture Partners)
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Pulnovo Medical. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.